Ito, Takeshi
Kawai, Yohei
Yasui, Yutaka
Iriguchi, Shoichi
Minagawa, Atsutaka
Ishii, Tomoko
Miyoshi, Hiroyuki http://orcid.org/0000-0001-7400-0714
Taketo, M. Mark
Kawada, Kenji http://orcid.org/0000-0003-4336-6937
Obama, Kazutaka
Sakai, Yoshiharu
Kaneko, Shin http://orcid.org/0000-0003-2291-4586
Funding for this research was provided by:
MEXT | Japan Society for the Promotion of Science
Collaborative research grant of Thyas Co., Ltd.
Article History
Received: 9 November 2020
Accepted: 7 May 2021
First Online: 7 June 2021
Competing interests
: S.K. is a founder, shareholder, and chief scientific officer at Thyas Co., Ltd. and received research funding from Thyas Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kirin Co., Ltd., TERUMO Co., Ltd., Astellas Pharma Co., Ltd. and Tosoh Co. Ltd. The remaining authors declare no competing interests.